Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study
Published in
Investigational new drugs, vol. 16, no. 3, p. 271-274Publication date
1998Abstract
Keywords
- Aged
- Antimetabolites, Antineoplastic/ therapeutic use
- Carcinoma, Squamous Cell/ drug therapy/secondary
- Female
- Head and Neck Neoplasms/ drug therapy/pathology
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local/ drug therapy
- Quinazolines/ therapeutic use
- Survival Analysis
- Thiophenes/ therapeutic use
UNIGE affiliation entities
Citation (ISO format)
SAMLOWSKI, W. E. et al. Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. In: Investigational new drugs, 1998, vol. 16, n° 3, p. 271–274.
Main files (1)
Article
Identifiers
- PID : unige:7561
- PMID : 10360608
